Not applicableStudy completedNCT04338009What this trial is testingElimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019Who this might be right forCOVID-19 University of Pennsylvania 152
Post-approval studies (Phase 4)Study completedNCT03476616What this trial is testingAntihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive PatientsWho this might be right forHypertensionObesity Hippocration General Hospital 198
Testing effectiveness (Phase 2)Ended earlyNCT01938664What this trial is testingA Pilot Study of Candesartan as a Treatment for Cocaine DependenceWho this might be right forCocaine Dependence Baylor College of Medicine 30
Post-approval studies (Phase 4)Study completedNCT04394117What this trial is testingControlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY DiseaseWho this might be right forCoronavirus Disease 2019COVID-19 The George Institute 787
Post-approval studies (Phase 4)Not Yet RecruitingNCT06704633What this trial is testingSacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural TanzaniaWho this might be right forHeart Failure Martin Rohacek 238
Post-approval studies (Phase 4)Study completedNCT03733145What this trial is testingAngiotensin II in General AnesthesiaWho this might be right forHypertension Wake Forest University Health Sciences 32
Not applicableStudy completedNCT02215733What this trial is testingThe Use of Angiotensin Receptor Blockers and the Risk of CancerWho this might be right forNeoplasm Boehringer Ingelheim 1,165,781
Post-approval studies (Phase 4)Study completedNCT00185068What this trial is testingAn Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With HypertensionWho this might be right forHypertension Daiichi Sankyo 110
Large-scale testing (Phase 3)WithdrawnNCT03315832What this trial is testingEfficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II StudyWho this might be right forAortic Valve StenosisValsartanAngiotensin Receptor Antagonists+3 more University Hospital, Limoges
Post-approval studies (Phase 4)Temporarily pausedNCT04330300What this trial is testingCoronavirus (COVID-19) ACEi/ARB InvestigationWho this might be right forHypertensionCOVID-19 National University of Ireland, Galway, Ireland 2,414
Large-scale testing (Phase 3)Ended earlyNCT00555217What this trial is testingVA NEPHRON-D: Diabetes iN Nephropathy StudyWho this might be right forKidney DiseaseNephropathyType 2 Diabetes US Department of Veterans Affairs 1,448
Post-approval studies (Phase 4)UnknownNCT00235287What this trial is testingPulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney DiseaseWho this might be right forKidney Failure, ChronicCardiovascular Diseases Herlev Hospital 60
Post-approval studies (Phase 4)Study completedNCT04353596What this trial is testingStopping ACE-inhibitors in COVID-19Who this might be right forSARS-CoV-2COVID-19 Medical University Innsbruck 216
Not applicableStudy completedNCT04318418What this trial is testingACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19Who this might be right forCOVID-19 Neuromed IRCCS 3,400
Not applicableStudy completedNCT01071642What this trial is testingThe Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary AngiographyWho this might be right forBlood Pressure Soroka University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT02358096What this trial is testingEvaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forChronic Kidney DiseaseType 2 Diabetes Astellas Pharma Europe B.V. 125
Large-scale testing (Phase 3)Study completedNCT01195662What this trial is testingBMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive MedicationWho this might be right forType 2 Diabetes AstraZeneca 2,245
Large-scale testing (Phase 3)Study completedNCT00098137What this trial is testingTrial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial FibrillationWho this might be right forHeart DiseaseArrhythmiaAtrial Fibrillation Atrial Fibrillation Network 422
Post-approval studies (Phase 4)Study completedNCT00607672What this trial is testingThe RAS, Fibrinolysis and Cardiopulmonary BypassWho this might be right forCoronary Artery DiseaseAngiotensin Converting EnzymeAngiotensin Receptor Blockers+3 more Vanderbilt University 111
Not applicableStudy completedNCT00528385What this trial is testingOptimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone SystemWho this might be right forChronic Kidney DiseaseProteinuria Medical University of Gdansk